Associated Papers
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.
Gorria T et al.
Cancers, 2024
TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.
Kuhn CK et al.
Plos One, 2023
37418389 (PubMed )
Supplement: pone.0281487.s006.xlsx › 5D_TERT_pm_subtypes
Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
Bai H et al.
Biomed Research International, 2021
Co-Occurrence of Hotspot Point Mutation and Novel Deletion Mutation of TERT Promoter in Solid Variant Papillary Thyroid Carcinoma in a Patient with Synchronous Esophageal Cancer.
Han J et al.
Diagnostics (basel, Switzerland), 2020
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer.
Trybek T et al.
Endocrinology, 2019
TERT promoter hotspot mutations in breast cancer.
Shimoi T et al.
Breast Cancer (tokyo, Japan), 2018
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.
Insilla AC et al.
Oncology Letters, 2018
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Liu R et al.
Nature Communications, 2018
29422527 (PubMed )
Supplement: 41467_2018_3033_MOESM1_ESM.pdf
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks.
Kalender Atak Z et al.
Genome Medicine, 2017
TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients.
Saito T et al.
Molecular and Clinical Oncology, 2016
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Macerola E et al.
Virchows Archiv : an International Journal of Pathology, 2015
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G et al.
European Journal of Endocrinology, 2015
Absence of TERT promoter mutations in esophageal adenocarcinoma.
van Nistelrooij AM et al.
International Journal of Cancer, 2014
Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Allory Y et al.
European Urology, 2014
Highly recurrent TERT promoter mutations in human melanoma.
Huang FW et al.
Science (new York, N.y.), 2013
Select a paper to view details